Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-06

Claudia C.S. Chini

High Impact

Researcher

Faculty Researcher

29 h-index 80 pubs 4,435 cited

  • Animals
  • NAD
  • Humans
  • Mice
  • ADP-ribosyl Cyclase 1
  • Aging
  • Adaptor Proteins, Signal Transducing
  • Male
  • Mice, Knockout
  • NAD+ Nucleosidase
  • Membrane Glycoproteins
  • Sirtuin 1
  • Female
  • Signal Transduction
  • Mice, Inbred C57BL

Biography and Research Information

OverviewAI-generated summary

Claudia C.S. Chini's research focuses on the metabolism of nicotinamide adenine dinucleotide (NAD+), a critical coenzyme involved in cellular energy production and signaling pathways. Her work investigates the roles of enzymes such as ADP-ribosyl cyclase 1 (CD38) and NAD+ nucleosidase in various physiological and pathological conditions, including aging, cardiac function, and reproductive health.

Her recent publications explore the implications of NAD+ metabolism in extending lifespan and healthspan in mouse models of aging, as well as its connection to spermatogenesis decline in aging mice. Chini's group has also examined the impact of CD38 suppression on cardiac function and exercise capacity, and the pro-inflammatory effects of dihydronicotinamide riboside, a NAD+ precursor, on macrophages. Furthermore, her research has identified the critical role of astrocyte NAD+ glycohydrolase in myelin injury and regeneration.

Chini leads a research group and has collaborated with researchers at the University of Arkansas for Medical Sciences, including Benjamin M. Stronach, Aaron Warren, Ha-Neui Kim, and Ana I. Coelho. Her scholarship metrics include an h-index of 29, with over 80 publications and 4,435 citations, reflecting her recognition as a highly cited researcher.

Metrics

  • h-index: 29
  • Publications: 80
  • Citations: 4,435

Selected Publications

  • Niacin (2026)
    Advances in Nutrition DOI OpenAlex
  • Estrogens protect bone mass by inhibiting NAD <sup>+</sup> metabolism in osteoclasts (2025)
    bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
  • Chronic Cellular <scp>NAD</scp> Depletion Activates a Viral Infection‐Like Interferon Response Through Mitochondrial <scp>DNA</scp> Leakage (2025)
    Aging Cell 8 citations DOI OpenAlex
  • Methylglyoxal Reshapes Hepatic and Adipose Tissue Metabolism and Increases Viability of Lymphocytes (2025)
    Cellular Physiology and Biochemistry DOI OpenAlex
  • An NAD+-dependent metabolic checkpoint regulates hematopoietic stem cell activation and aging (2024)
    Nature Aging 45 citations DOI OpenAlex
  • Heavy-chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs (2023)
    Scientific Reports 11 citations DOI OpenAlex
  • Supplementary Figure 2 from Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors (2023)
  • Supplementary Figure 4 from Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors (2023)
  • Supplementary Figure 6 from Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors (2023)
  • Supplementary Figure 3 from Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors (2023)
  • Supplementary Figure Legend from Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors (2023)
  • Supplementary Figure 1 from Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors (2023)
  • supplementary figures from SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway (2023)
  • supplementary figure legends from SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway (2023)
  • Supplementary Figure 5 from Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors (2023)

View all publications on OpenAlex →

Collaboration Network

9 Collaborators 3 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics